Compare Western Union Co (WU) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Western Union Co vs Zimmer Biomet Holdings Inc — how do they compare? Western Union Co trades at $6.15 (market cap $1.97B), while Zimmer Biomet Holdings Inc trades at $89.91 (market cap $16.95B). The key difference: Zimmer Biomet Holdings Inc is far larger — about 8.6× Western Union Co's market cap, and Western Union Co pays the higher dividend (14.85%). Which is the better fit depends on your goals — on Pluang, investors hold Western Union Co for 96 Days and Zimmer Biomet Holdings Inc for 89 Days on average.
| WU | ZBH | |
|---|---|---|
Market Cap | $1.97B | $16.95B |
Volume | 10,235,212 | 2,505,240 |
Sector | Financials | Health |
52-Week High | $10.28 | $103.98 |
52-Week Low | $5.90 | $79.58 |
Typical Hold Time | 96 Days | 89 Days |
Enterprise Value | $1.88B | $24.02B |
Dividend Yield | 14.85% | 1.08% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Western Union (WU) trades at $6.12, showing minimal daily movement with a 0.16% gain. The stock demonstrates strong profitability with a 43.97% ROE and attractive valuation metrics including a 5.1 P/E ratio. Recent earnings have been mixed with two misses in the last three quarters, while technical indicators show a bullish overall signal despite bearish moving averages. The company's $200 million efficiency plan and Intermex acquisition represent significant strategic initiatives.
WU presents a value opportunity with deep discount valuation, but faces earnings volatility and competitive pressures. The 12.24% analyst buy rating reflects cautious optimism, with the $6.86 consensus target offering 12% upside. Key risks include integration challenges from acquisitions and margin pressure from digital transformation costs.
Zimmer Biomet (ZBH) trades at $89.14, up 0.73% today, with a bearish technical signal but strong recent earnings beats. The stock shows robust fundamentals with a 69.87% gross margin and 2025 revenue of $8.23B, though net income margin has declined from 2023 peaks. Analyst consensus is a Buy with a $103.11 target, indicating potential upside, supported by a steady dividend and institutional accumulation.
The outlook is mixed: valuation metrics like a P/E of 21.57 appear reasonable, and earnings momentum is positive, but technical weakness and rising debt-to-asset ratios pose risks. Investment appeal hinges on execution of commercial transformations and procedure volume recovery, balancing growth prospects against competitive and operational headwinds.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Western Union Co
Western Union provides domestic and international money transfers through its global network of about 500,000 outside agents. It is the largest money transfer company in the world and one of only a few companies with a truly global agent network.
Read more on WU →About Zimmer Biomet Holdings Inc
Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.
Read more on ZBH →
